Chiral ruthenium(ii) complex as potent radiosensitizer of125I through DNA-damage-mediated apoptosis

Chemistry 03 medical and health sciences 0302 clinical medicine
DOI: 10.1039/c8ra03383h Publication Date: 2018-06-06T07:24:17Z
ABSTRACT
SyntheticLR042can be further developed as a radiosensitizer of125I by inducing DNA-damage-mediated apoptosis for cancer therapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....